Activity II- Week 4- Heba Malik

Ovarian cancer afflicts over 20,000 women each year, as of 2006, in America, with over 15,000 of those cases resulting in death (Jemal 107). This is a very significant figure because even epidemics like Ebola in the region cannot compare. Ebola has only killed over 11,000 people this year, which is almost half the number of people that ovarian cancer afflicts each year (“What ‘100 Percent Effective’ 2015).  Additionally, a vaccine was just found for Ebola that is 100% affective against the Ebola virus, and that is going to be one of the most talked about subjects in the media, regardless of the circumstances involved. Ovarian cancer does not have as much media exposure, and is not as sensationalized as Ebola. The cancer attacks normal cells that exist in ovarian cells in women. Regardless of what these women are going through, they must endure severe chemotherapy or other extreme treatments in order to survive. There are many diseases that afflict women with horrible symptoms, and ovarian cancer is one of them. Ovarian cancer is an integral issue regarding women, in America and all parts of the world. While this disease is not contagious, as it is a cancer, it is still prevalent, and leads to many deaths and requires surgery to treat, if the cancer is not terminal. So far, we have been most successful in our fight against ovarian cancer in the recent past Ovarian cancer has no cure or an effective measure against stopping the fatal disease, as cancer is an incredibly tough medical phenomenon to prevent or treat. Additionally ovarian cancer is diagnosed through pelvic exams, ultrasounds, biopsies or CAT scans. Sometimes, the only way to stop the spread of this cancer is by removing both ovaries. While this is effective, it renders women unable to have babies, and caused much stress in their lives.  Additionally, of the women that suffer from ovarian cancer, almost 15,000 of them die per year, even though the cancer accounts for only 3% of all cancers in women (Jemal 107). It is still the third most prevalent type of cancer in women, the most prevalent being breast cancer. Of the women that are within the disease stage of the cancer, in stage III and IV cancers, 10.3% of them are under 45 years of age, with the highest percentage of 27.6 existing within ages 55-64 (Yancik 521). Additionally, according to a study in the Journal of Immunology Research, scientists found that “advances in understanding the role of immune system in the pathogenesis of cancer have led to the rapid evolvement of immunotherapy” (De Felice 2015). Scientists are looking to study further what implications the immune systems may have on ovarian cancer, and ovarian cancer needs to have more media presence in order to garner funding and find a cure. I wish there were more options to stymie the disease, but cancers are incredibly tough to treat, and they often require removal of the organs to survive. In patients with ovarian cancer, the ovaries have to be removed oftentimes, which prevents women from having babies and is not viable for those that are trying to rear children.

 

“What ‘100 Percent Effective’ Means for That Ebola Vaccine.” Wired.com. Conde Nast Digital, 4 Aug. 2015. Web. 10 Aug. 2015.

Jemal, Ahmedin, et al. “Cancer statistics, 2006.” CA: a cancer journal for clinicians 56.2 (2006): 106-130.

Yancik, Rosemary. “Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality.” Cancer 71.S2 (1993): 517-523.

De Felice, Francesca et al. “Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors.” Journal of Immunology Research 2015 (2015): 191832.PMC. Web. 10 Aug. 2015.

Leave a Reply